VD-001
Actinic Keratosis
Phase 2BActive
Key Facts
About Vidac Pharma
Israeli biotech advancing metabolic reprogramming therapies for cancer and dermatology.
View full company profileTherapeutic Areas
Other Actinic Keratosis Drugs
| Drug | Company | Phase |
|---|---|---|
| 15dPMJ2 | Claradele Pharmaceuticals | Pre-clinical |
| Skinject Patch | Skinject | Research |
| Bimiralisib (PQR309) | Torqur | Phase 2 |
| RLS-1496 | Rubedo Life Sciences | Phase 1 |
| Klisyri (tirbanibulin) | Almirall | Marketed |